Related Experiment Videos
Optimum treatment of streptococcal pharyngitis
F Scaglione1, G Demartini, M M Arcidiacono
1Department of Pharmacology, University of Milan, Italy.
Drugs
|January 1, 1997
Summary
Penicillin and cephalosporin antibiotics are recommended for treating group A streptococcal pharyngitis in children and adolescents. These treatments are effective, though cephalosporins may be preferred for recurrent infections.
Area of Science:
- Infectious Diseases
- Pediatrics
- Pharmacology
Background:
- Group A beta-hemolytic streptococci cause most cases of streptococcal pharyngitis in children and adolescents.
- While penicillin has reduced rheumatic fever, recent studies show increasing penicillin treatment failures.
- Erythromycin, an alternative for penicillin-allergic patients, has reported failure rates up to 24.7% and increasing resistance.
Purpose of the Study:
- To evaluate the efficacy of different antibiotic treatments for streptococcal pharyngitis.
- To compare the clinical failure rates of penicillins, cephalosporins, and erythromycin.
- To provide evidence-based recommendations for first-line antibiotic therapy.
Main Methods:
- Literature review of studies on pharyngitis treatment.
- Analysis of clinical failure rates associated with different antibiotic classes.
- Assessment of resistance patterns and adverse effect profiles.
Main Results:
- Penicillin treatment failures have been reported with increasing frequency.
- Cephalosporins demonstrate a lower rate of clinical failure compared to penicillins.
- Erythromycin exhibits significant resistance and high failure rates in treating pharyngitis.
Conclusions:
- Oral penicillins and cephalosporins should be considered first-line agents for culture-confirmed group A streptococcal tonsillopharyngitis.
- Cephalosporins are particularly useful for managing recurrent streptococcal tonsillopharyngitis.
- Antibiotic stewardship is crucial given increasing resistance and treatment failures.